Ten years with biologics: to whom do data on effectiveness and safety apply?-Reference-Cited by-同舟云学术

Ten years with biologics: to whom do data on effectiveness and safety apply?

Published:2010-11-16 Issue:1 Volume:50 Page:204-213
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Simard J. F.,Arkema E. V.,Sundstrom A.,Geborek P.,Saxne T.,Baecklund E.,Coster L.,Dackhammar C.,Jacobsson L.,Feltelius N.,Lindblad S.,Rantapaa-Dahlqvist S.,Klareskog L.,van Vollenhoven R. F.,Neovius M.,Askling J.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/50/1/204/5067239/keq326.pdf

Reference13 articles.

1. Changing pattern in the prescription of biological treatment in rheumatoid arthritis. A 7-year follow-up of 1839 patients in southern Sweden

2. Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry

3. Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abatacept retention and clinical effectiveness in patients with rheumatoid arthritis in a real‐world setting in Taiwan;International Journal of Rheumatic Diseases;2024-07

2. Association of large joint involvement at the start of biological disease‐modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study;International Journal of Rheumatic Diseases;2024-03

3. Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study;Rheumatology;2024-02-06

4. Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort;Arthritis Research & Therapy;2024-01-09

5. 25 years of biologic DMARDs in rheumatology;Nature Reviews Rheumatology;2023-11-02